- Home
- AGMH vs VTAK Comparison
AGMH vs VTAK Comparison
Compare AGMH & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGMH
- VTAK
- Stock Information
- Founded
- AGMH 2015
- VTAK 2002
- Country
- AGMH Hong Kong
- VTAK United States
- Employees
- AGMH N/A
- VTAK N/A
- Industry
- AGMH EDP Services
- VTAK Medical/Dental Instruments
- Sector
- AGMH Technology
- VTAK Health Care
- Exchange
- AGMH Nasdaq
- VTAK Nasdaq
- Market Cap
- AGMH 3.5M
- VTAK 3.9M
- IPO Year
- AGMH 2018
- VTAK 2018
- Fundamental
- Price
- AGMH $1.97
- VTAK $3.04
- Analyst Decision
- AGMH
- VTAK
- Analyst Count
- AGMH 0
- VTAK 0
- Target Price
- AGMH N/A
- VTAK N/A
- AVG Volume (30 Days)
- AGMH 67.6K
- VTAK 3.1M
- Earning Date
- AGMH 05-13-2025
- VTAK 08-11-2025
- Dividend Yield
- AGMH N/A
- VTAK N/A
- EPS Growth
- AGMH N/A
- VTAK N/A
- EPS
- AGMH 6.43
- VTAK N/A
- Revenue
- AGMH $32,044,575.00
- VTAK $600,000.00
- Revenue This Year
- AGMH N/A
- VTAK $822.86
- Revenue Next Year
- AGMH N/A
- VTAK $168.42
- P/E Ratio
- AGMH $0.29
- VTAK N/A
- Revenue Growth
- AGMH N/A
- VTAK 37.62
- 52 Week Low
- AGMH $1.09
- VTAK $2.49
- 52 Week High
- AGMH $109.50
- VTAK $43.70
- Technical
- Relative Strength Index (RSI)
- AGMH 35.63
- VTAK 44.02
- Support Level
- AGMH $1.94
- VTAK $2.70
- Resistance Level
- AGMH $2.43
- VTAK $4.31
- Average True Range (ATR)
- AGMH 0.17
- VTAK 0.37
- MACD
- AGMH -0.00
- VTAK 0.03
- Stochastic Oscillator
- AGMH 13.21
- VTAK 30.22
About AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.